Results 131 to 140 of about 49,774 (199)

Straight to the Dome - Cefepime Induced Neurotoxicity

Translation
Hannah Starbuck, Aditya Acharya, Zachary Holtzapple, Muhammad Usman Ali   +3 more
doaj   +1 more source

Activity of novel antibiotics against dual metallo-Beta-lactamase producing Enterobacter hormaechei clinical isolates. [PDF]

JAC Antimicrob Resist
Solar C, Diaz L, Soto K, Martínez JRW, Canales N, Bergman Y, Peters A, Araos R, García P, Tamma PD, Munita JM.   +10 more
europepmc   +1 more source

Real-World Evidence and Multidrug Resistant Infections: How Can We Leverage RWE to Improve Patient Outcome with the Novel Beta-Lactam and Beta-Lactam/Beta-Lactamase Inhibitor Combinations. [PDF]

Infect Drug Resist
Gatti M, Pea F.
europepmc   +1 more source

In vitro activity of cefepime/zidebactam against sulbactam/durlobactam-susceptible and -resistant Acinetobacter baumannii clinical isolates. [PDF]

J Antimicrob Chemother
Tascini C, Bianco G, Bonomo RA, Gaibani P.   +3 more
europepmc   +1 more source

An immune-mediated effect of the antibiotic cefiderocol on LPS-induced acute lung injury. [PDF]

Antimicrob Agents Chemother
Hao M, Li Y, Bi Y, Liu S, Ju M.
europepmc   +1 more source

<i>Delftia</i> spp as Opportunistic Pathogens: a narrative review. [PDF]

New Microbes New Infect
Ryan MP, Tony Pembroke J.
europepmc   +1 more source

Cefepime/enmetazobactam for Gram-negative periprosthetic joint infections? A randomized porcine study on target tissue pharmacokinetics. [PDF]

J Antimicrob Chemother
Nielsen MBD, Mikkelsen MKD, Rasmussen HC, Hvistendahl MA, Lützhøft CH, Slater J, Crocoll C, Poborsky M, Jørgensen NP, Soriano A, Stilling M, Bue M.   +11 more
europepmc   +1 more source

Combined effects of mesenchymal stromal cells and antibiotic therapy on Enterobacter ventilator-associated pneumonia in rabbits. [PDF]

Respir Res
Jacquier M, Laroye C, Bensoussan D, Nguyen S, Croisier D, Richard C, Boidot R, Masson D, Charles PE, Blot M.   +9 more
europepmc   +1 more source

Cumulative cefepime exposure in cancer patients is associated with an increased risk of ertapenem non-susceptible, meropenem susceptible Enterobacterales bacteremia. [PDF]

Microbiol Spectr
Stabler AV, Shropshire WC, Young A, Feng C, Hwang H, Shelburne SA, Vuong NN, Borjan J.   +7 more
europepmc   +1 more source

The shift from "MIC-Only" back to carbapenemase testing among carbapenem-resistant Enterobacterales: what clinical laboratories need to know about updated CLSI guidance. [PDF]

J Clin Microbiol
Simner PJ.
europepmc   +1 more source